Literature DB >> 31603541

Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.

Michael Weitzendorfer1,2, Stavros A Antoniou3, Philipp Schredl1, Kai Witzel1,4, Isabella C Weitzendorfer5, Alexandra Majerus1, Klaus Emmanuel1, Oliver O Koch1.   

Abstract

OBJECTIVES: The aim of this study was to compare the diagnostic accuracy of salivary pepsin with oropharyngeal pH monitoring using the Restech measurement system (Dx-pH) for the diagnosis of laryngopharyngeal reflux (LPR). STUDY
DESIGN: Prospective cohort study.
METHODS: Seventy patients with primary symptoms related to LPR underwent gastroscopy, high-resolution manometry, pH throughout 24-hour monitoring (MII-pH), and barium esophagography between October 2015 and May 2018. In addition, an ear, nose, and throat examination was performed, including assessment of Belafsky Reflux Finding Score (RFS). Clinical symptoms were evaluated with the Belafsky Reflux Symptom Index (RSI) and the Gastrointestinal Quality of Life Index (GIQLI). Simultaneous to MII-pH, pepsin determination and Dx-pH were performed.
RESULTS: Of 70 patients, 41 (58.6%) subjects with a pathological DeMeester score showed higher mean values of pepsin (mean value: 216 ng/mL, 95% confidence interval [CI]: 172 to 260), compared to patients with a normal DeMeester score (mean value: 161 ng/mL, 95% CI: 115 to 207). Salivary pepsin showed a specificity of 86.2% and sensitivity of 41.5% for diagnosing LPR using the optimal cutoff value of 216 ng/mL. Furthermore, a significant correlation between the values of salivary pepsin and the RSI score was seen in patients with pathological results in MII-pH (r = 0.344; P = 0.046). However, elevated Dx-pH measurements showed no significant correlation with either MII-pH, RSI score, RFS score, or GIQLI score, or with the results of pepsin measurement.
CONCLUSION: Pepsin measurement in saliva could be an alternative tool to assist office-based diagnosis of LPR, whereas Dx-pH does not seem to be an adequate test. LEVEL OF EVIDENCE: 2B Laryngoscope, 130:1780-1786, 2020.
© 2019 The Authors. The Laryngoscope published by Wiley Periodicals, Inc. on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  GERD; laryngopharyngeal reflux; oropharyngeal pH monitoring; salivary pepsin

Year:  2019        PMID: 31603541     DOI: 10.1002/lary.28320

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

Review 1.  How I Approach Laryngopharyngoesophageal Reflux (LPR).

Authors:  Kaleigh Stabenau; Nikki Johnston
Journal:  Curr Gastroenterol Rep       Date:  2021-11-19

2.  Does hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring for the diagnosis of laryngopharyngeal reflux have to be 24 h?

Authors:  Jinhong Zhang; Xiaoyu Wang; Jiasen Wang; Jing Zhao; Chun Zhang; Zhi Liu; Jinrang Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-21       Impact factor: 3.236

3.  The effects of Helicobacter pylori eradication therapy on salivary pepsin concentration in patients with laryngopharyngeal reflux.

Authors:  Qing-Qing Zhang; Meng Xie; Rui-Xin Guo; Xiao-Hong Liu; Si-Jing Ma; Yang-Juan Chen; Min-Juan Yang; Ye-Wen Shi; Xiao-Yong Ren; Hua-Nan Luo
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-08       Impact factor: 3.236

4.  Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease.

Authors:  Hailong Shen; Yanxun Han; Changyu Yao; Ye Tao; Jing Wu; Chaobing Gao; Feihu Wu; Yehai Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-14       Impact factor: 3.236

Review 5.  Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.

Authors:  Vivianne Landry; Patrick Coburn; Karen Kost; Xinyu Liu; Nicole Y K Li-Jessen
Journal:  Front Med (Lausanne)       Date:  2022-06-06

6.  Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.

Authors:  Rocco Plateroti; Marta Sacchetti; Giuseppe Magliulo; Andrea Maria Plateroti; Annalisa Pace; Antonietta Moramarco; Alessandro Lambiase; Alice Bruscolini
Journal:  Life (Basel)       Date:  2020-09-15

7.  Multitime point pepsin testing can double the rate of the diagnosis of laryngopharyngeal reflux.

Authors:  Jinhong Zhang; Jinrang Li; Yanping Zhang; Qian Nie; Ran Zhang; Xiaoyu Wang; Xingwang Jiang; Yingying Wu; Runze Wu; Xinxin Bi; Xiaohuan Cui; Hui Song; Taotao Ran; Lina Li
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-19

8.  Obstructive sleep apnoea patients vs laryngopharyngeal reflux disease: Non-invasive evaluation with NBI and pepsin detection in tears.

Authors:  Annalisa Pace; Valeria Rossetti; Alessandro Milani; Giannicola Iannella; Salvatore Cocuzza; Antonino Maniaci; Danilo Alunni Fegatelli; Annarita Vestri; Antonio Greco; Marco De Vincentiis; Francesca Giovannetti; Rocco Plateroti; Giuseppe Magliulo
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

Review 9.  [Current possibilities and challenges in the diagnosis of laryngopharyngeal reflux].

Authors:  D Runggaldier; J Hente; M Brockmann-Bauser; D Pohl; J E Bohlender
Journal:  HNO       Date:  2021-02-22       Impact factor: 1.284

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.